Baeuerle Patrick 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 26, 2019
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Sale
Common Stock
2019-12-23$15.44/sh−84,907$1,310,964→ 350,786 total(indirect: By APAK Solutions GmbH) - Sale
Common Stock
2019-12-20$15.16/sh−32,022$485,454→ 435,693 total(indirect: By APAK Solutions GmbH)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- [F2]$15.16 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F4]$15.44 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $16.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.